Guest: Ryan DeBoer

Guest: Bryan Nolan

In a recent discussion with Bryan Nolan, Founder and CEO of myBiometry, Bryan shared what early lessons he had that led him to founding the company. MyBiometry is a remote monitoring company with initial focus on better asthma and COPD management. Bryan, thanks for joining me on TechTalks.

Guest: Ryan DeBoer

In this Tech Talks episode, Ryan DeBoer, CEO of The Shape Sensing Company, discusses their innovative platform that integrates a thin, flexible optical fiber into medical devices. This technology offers surgeons a 3D perspective during complex procedures like endovascular aneurysm repair (EVAR), addressing the limitations of current standard care. By enhancing visualization, this technology can reduce procedure times, minimize radiation exposure, and improve patient outcomes. Join us as Ryan shares how this innovation is set to transform the field of minimally invasive surgery.

Guest: David Constantine

Neuromodulation is a rapidly growing market, with significant investments in pelvic health, including Boston Scientific's $3.4 billion acquisition of Axonics and funding for Amber Therapeutics, Neuspera Medical, and Avation Medical. David Constantine, Co-Founder and CEO of Juniper Biomedical, has leveraged his career experiences to drive their mission of revolutionizing pelvic health through precision neuromodulation. His passion for impactful work highlights the importance of finding meaningful career paths that motivate and sustain us through challenges. This conversation with David underscored the timely relevance of their innovative approach in transforming patient outcomes.

Guests: Vending Kothari & Mike Cogswell

As cancer treatments become better at fighting the disease itself, there is much to do regarding side effects like oral mucositis. This condition is common, up to 80% of those receiving high dose chemotherapy can suffer from this painful and potentially deadly side effect. There is hope with technology stemming from MuReva Phototherapy.  In this chat with Vedang Kothari, the founder of MuReva, he explained the effectiveness of photomodulation for this condition, and the treatment modality the team has created.

Guest: David Kuraguntla

I sat down with David Kuraguntla, CEO of Alio, to discuss their groundbreaking multi-metric wearable, the first to monitor potassium levels, a key health indicator. With FDA clearance and impressive data, Alio aims to revolutionize healthcare with valuable, actionable information. David shared insights into the development journey and challenges faced. Tune in to explore the future of healthcare technology and innovation.